BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 11963922)

  • 1. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.
    Yung B; Noormohamed FH; Kemp M; Hooper J; Lant AF; Hodson ME
    Diabet Med; 2002 Mar; 19(3):221-6. PubMed ID: 11963922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance, β-cell dysfunction and differences in curves of plasma glucose and insulin in the intermediate points of the standard glucose tolerance test in adults with cystic fibrosis.
    Cano Megías M; González Albarrán O; Guisado Vasco P; Lamas Ferreiro A; Máiz Carro L
    Endocrinol Nutr; 2015 Feb; 62(2):91-9. PubMed ID: 25444978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoglycemia and Islet Dysfunction Following Oral Glucose Tolerance Testing in Pancreatic-Insufficient Cystic Fibrosis.
    Kilberg MJ; Harris C; Sheikh S; Stefanovski D; Cuchel M; Kubrak C; Hadjiliadis D; Rubenstein RC; Rickels MR; Kelly A
    J Clin Endocrinol Metab; 2020 Oct; 105(10):3179-89. PubMed ID: 32668452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Normal adiponectin levels despite abnormal glucose tolerance (or diabetes) and inflammation in adult patients with cystic fibrosis.
    Hammana I; Malet A; Costa M; Brochiero E; Berthiaume Y; Potvin S; Chiasson JL; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2007 Jun; 33(3):213-9. PubMed ID: 17418606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of glucose tolerance, beta-cell function and peripheral insulin sensitivity in cystic fibrosis patients with fasting euglycemia.
    Lombardo F; De Luca F; Rosano M; Sferlazzas C; Lucanto C; Arrigo T; Messina MF; Crisafulli G; Wasniewska M; Valenzise M; Cucinotta D
    Eur J Endocrinol; 2003 Jul; 149(1):53-9. PubMed ID: 12824866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis.
    Tofé S; Moreno JC; Máiz L; Alonso M; Escobar H; Barrio R
    Eur J Endocrinol; 2005 Feb; 152(2):241-7. PubMed ID: 15745932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 1-h oral glucose tolerance test glucose and insulin values are associated with markers of clinical deterioration in cystic fibrosis.
    Coriati A; Ziai S; Lavoie A; Berthiaume Y; Rabasa-Lhoret R
    Acta Diabetol; 2016 Jun; 53(3):359-66. PubMed ID: 26215312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of macrolides, nutritional support and respiratory therapies in diabetes and normal glucose tolerance in cystic fibrosis. A retrospective analysis of a cohort of adult and younger patients.
    Megías MC; Albarrán OG; Vasco PG; Ferreiro AL; Carro LM
    Diabetes Metab Syndr; 2015; 9(1):1-6. PubMed ID: 25450813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose intolerance in cystic fibrosis as a determinant of pulmonary function and clinical status.
    Lavie M; Fisher D; Vilozni D; Forschmidt R; Sarouk I; Kanety H; Hemi R; Efrati O; Modan-Moses D
    Diabetes Res Clin Pract; 2015 Dec; 110(3):276-84. PubMed ID: 26508676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of insulin secretion indices in cystic fibrosis patients.
    Hammana I; Potvin S; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    J Cyst Fibros; 2009 Dec; 8(6):378-81. PubMed ID: 19782008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between leptin and insulin levels in adults with cystic fibrosis.
    Ziai S; Belson L; Malet A; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    Diabetes Metab; 2012 Feb; 38(1):34-9. PubMed ID: 21925915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOMA indices as screening tests for cystic fibrosis-related diabetes.
    Toin T; Reynaud Q; Denis A; Durieu I; Mainguy C; Llerena C; Pin I; Touzet S; Reix P
    J Cyst Fibros; 2022 Jan; 21(1):123-128. PubMed ID: 34090803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance with altered secretory kinetics and reduced proinsulin in cystic fibrosis patients.
    Holl RW; Wolf A; Thon A; Bernhard M; Buck C; Missel M; Heinze E; von der Hardt H; Teller WM
    J Pediatr Gastroenterol Nutr; 1997 Aug; 25(2):188-93. PubMed ID: 9252906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced pancreatic insulin release and reduced peripheral insulin sensitivity contribute to hyperglycaemia in cystic fibrosis.
    Holl RW; Heinze E; Wolf A; Rank M; Teller WM
    Eur J Pediatr; 1995 May; 154(5):356-61. PubMed ID: 7641765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycaemic regulation and insulin secretion are abnormal in cystic fibrosis pigs despite sparing of islet cell mass.
    Uc A; Olivier AK; Griffin MA; Meyerholz DK; Yao J; Abu-El-Haija M; Buchanan KM; Vanegas Calderón OG; Abu-El-Haija M; Pezzulo AA; Reznikov LR; Hoegger MJ; Rector MV; Ostedgaard LS; Taft PJ; Gansemer ND; Ludwig PS; Hornick EE; Stoltz DA; Ode KL; Welsh MJ; Engelhardt JF; Norris AW
    Clin Sci (Lond); 2015 Jan; 128(2):131-42. PubMed ID: 25142104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peak glucose during an oral glucose tolerance test is associated with future diabetes risk in adults with cystic fibrosis.
    Bonhoure A; Potter KJ; Colomba J; Boudreau V; Bergeron C; Desjardins K; Carricart M; Tremblay F; Lavoie A; Rabasa-Lhoret R
    Diabetologia; 2021 Jun; 64(6):1332-1341. PubMed ID: 33693987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.